IGC Pharma (IGC) Finished Goods (2020 - 2026)
IGC Pharma (IGC) reported Finished Goods of $191000.0 for Q1 2026, down 25.39% year-over-year from $256000.0 in Q1 2025, and down 1.55% quarter-over-quarter from $194000.0 in Q4 2025.
IGC Pharma (IGC) Finished Goods (2020 - 2026) Analysis & Trends
IGC Pharma (IGC) has 7 years of Finished Goods data on file, last reported at $191000.0 in Q1 2026.
- Finished Goods for Q1 2026 came in at $191000.0, down 25.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $191000.0 (down 25.39% YoY), and the FY2026 annual result was $191000.0, down 25.39% from the prior year.
- Finished Goods fell to $191000.0 in Q1 2026 per IGC's latest filing, from $194000.0 in the prior quarter.
- Over five years, Finished Goods peaked at $801000.0 in Q3 2022 and troughed at $191000.0 in Q1 2026.
- A 5-year average of $458705.9 and a median of $441000.0 in 2024 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2024 and 2025: Finished Goods slipped 17.26% in 2024, then plunged 47.52% in 2025.
- A 5-year view of Finished Goods shows it stood at $706000.0 in 2022, then retreated by 27.62% to $511000.0 in 2023, then fell by 28.77% to $364000.0 in 2024, then plunged by 46.7% to $194000.0 in 2025, then slipped by 1.55% to $191000.0 in 2026.
- Business Quant data shows IGC's Finished Goods at $191000.0 in Q1 2026, $194000.0 in Q4 2025, and $212000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 191,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Sep 30, 2025 | 212,000.00 |
| Jun 30, 2025 | 271,000.00 |
| Mar 31, 2025 | 256,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 404,000.00 |
| Jun 30, 2024 | 397,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 511,000.00 |
| Sep 30, 2023 | 498,000.00 |
| Jun 30, 2023 | 550,000.00 |
| Mar 31, 2023 | 533,000.00 |
| Dec 31, 2022 | 706,000.00 |
| Sep 30, 2022 | 801,000.00 |
| Jun 30, 2022 | 752,000.00 |
| Mar 31, 2022 | 717,000.00 |
| Dec 31, 2021 | 889,000.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 948,000.00 |